HOME >> MEDICINE >> NEWS
UT Southwestern receives $1.7 million grant to study effects of long-term space travel on the heart

DALLAS - Oct. 24, 2001 - Space researchers at UT Southwestern have received a $1.7 million grant from the National Aeronautics and Space Administration to study why the heart decreases in size during long-term space travel.

Cardiac atrophy, or a decrease in heart mass, affects the heart's pumping ability and causes the heart to shrink and become stiff. This debilitating condition is also associated with orthostatic intolerance, or the inability to stand upright, and has been documented in short-term space flights.

"There has been some concern that if cardiac atrophy is severe then the risk of arrhythmias (abnormal heart rhythms) may increase," said Dr. Benjamin Levine, principal investigator on the study and medical director of the Institute for Exercise and Environmental Medicine, a collaboration between UT Southwestern and Presbyterian Hospital of Dallas.

"There has been at least one report of a life-threatening arrhythmia in one of the astronauts aboard the Russian Space Station Mir," he said. "Our goal is to clearly define the clinical manifestations of cardiac atrophy during long-duration space flight and obtain information that may provide insight into the risk for cardiac arrhythmias."

This condition may be a significant limiting factor for extended space missions, specifically the Mission to Mars, said Dr. Gunnar Blomqvist, professor of internal medicine and physiology and director of the NASA Specialized Center of Research and Training in Physiology at UT Southwestern from 1993 to 1998.

Before astronauts take off for the Mission to Mars, which is at least a 2 year trip, researchers hope to identify measures that can be taken to reverse cardiac atrophy.

Levine recently completed a bed-rest study and found that exercise training while reclining prevented atrophy of the heart.

"We think that cardiac atrophy is reversible and potentially can be prevented with sufficient exercise," Levine said.

T
'"/>

Contact: Amy Shields
Amy.Shields@UTSouthwestern.edu
214-648-3404
UT Southwestern Medical Center
24-Oct-2001


Page: 1 2

Related medicine news :

1. NASA awards $9.8 million NSCOR grant to UT Southwestern to study effects of space radiation exposure
2. UT Southwestern doctors track Oklahoma Alzheimers patients via telemedicine
3. Auditory screening for newborns can be successful, UT Southwestern researchers report
4. Exercise helps reduce symptoms of depression, UT Southwestern researchers find
5. UT Southwestern researchers find calcium intake contributing factor in formation of kidney stones
6. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
7. Donald W. Reynolds Foundation awards UT Southwestern $12 million to continue Dallas Heart Study
8. Patients with severe depression improve using guidelines developed by UT Southwestern researchers
9. UT Southwesterns Dr. Charles Pak receives international award for kidney-stone research
10. Excess body weight linked to formation of uric acid kidney stones, UT Southwestern researchers find
11. UT Southwestern researchers discover first effective treatment for exercise disorder

Post Your Comments:
(Date:5/23/2013)... important human pathogen that can cause rapidly progressing, life ... said., "Until now we have not known how it ... long-standing mystery how it attaches to the airway to ... not get any symptoms, while some people progress to ... know the detail of how the bacterium colonises the ...
(Date:5/23/2013)... WEDNESDAY, May 22 (HealthDay News) -- The success of an ... with a serious airway malformation sheds light on new technology ... report in the May 23 New England Journal of ... At first, the baby born five weeks early seemed perfectly ... when he was 6 weeks old. Just two weeks later, ...
(Date:5/23/2013)... DRE, Inc. is now offering the ... solution to upgrade older model DRE or BFW halogen ... system. , DRE and BFW customers can easily ... halogen headlights to LED with DRE’s American-made Xavier-C3 LED ... Kit provides a bright, clean and even field of ...
(Date:5/23/2013)... 2013 In Florida, residents have not been ... mean, however, that Florida’s good luck will continue, warns Rick ... year, he encourages residents, it is important to prepare as ... are predicting there to be a 50-percent chance that a ... hurricane season lasting from June 1 to November 30 in ...
(Date:5/23/2013)... Natchitoches, LA (PRWEB) May 23, 2013 The ... website, has showed that Louisiana still tops the rest of ... annual average of $2,699 is more than double of that ... factors determine auto insurance rates, and those factors vary from ... that may be causing these high rates. , Compared ...
Breaking Medicine News(10 mins):Health News:New discovery in fight against deadly meningococcal disease 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2Health News:Cunningham Financial Group Wants Motorists to Understand Their Rates as Louisiana’s Auto Insurance Rates Remain the Highest in the Nation 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, ... announced today that it will present new results ... an industry conference sponsored by the PML Consortium ... Idec).  JC polyomavirus (JCV) is the causative agent ... tyrosine kinase inhibitor in an extended release formulation, ...
(Date:5/23/2013)... 2013 InspireMD, Inc. ("InspireMD" ... in embolic protection stents, today announced new 6-month ... Elevation Reperfusion) trial demonstrating that the MGuard Embolic ... eluting stents in all-cause mortality in ST segment ... trial were presented at the InspireMD STEMI Symposium ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
Cached News: